Cargando…

Cardiovascular risk management in patients using antipsychotics: it is time to take action

Detalles Bibliográficos
Autores principales:	Bischoff, Erik W. M. A., Jakobs, Kirsti M., Assendelft, Willem J. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604922/ https://www.ncbi.nlm.nih.gov/pubmed/33131496 http://dx.doi.org/10.1186/s12916-020-01811-7

Ejemplares similares

Cardiovascular risk management in patients with severe mental illness or taking antipsychotics: A qualitative study on barriers and facilitators among dutch general practitioners
por: Jakobs, Kirsti, et al.
Publicado: (2022)

Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice
por: Jakobs, Kirsti M., et al.
Publicado: (2020)

Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?
por: Azfr Ali, Ruba Saleh, et al.
Publicado: (2021)

Communicating health risks in science publications: time for everyone to take responsibility
por: Freeman, Alexandra L. J., et al.
Publicado: (2018)

Take time to sharpen the saw
por: Prajna, Venkatesh
Publicado: (2018)

Commentary: Take your time!
por: Miceli, Antonio
Publicado: (2021)

Taking action on developmental toxicity: Scientists’ duties to protect children
por: Shrader-Frechette, Kristin
Publicado: (2012)

Urgent need to take action on reducing postoperative respiratory complications
por: Le, Lan My, et al.
Publicado: (2021)

Intensive risk factor management and cardiovascular autonomic neuropathy in type 2 diabetes in the Action to Control Cardiovascular Risk in Diabetes trial: A post‐hoc analysis
por: Aso, Yoshimasa
Publicado: (2021)

Reducing Racial Inequities in Health: Using What We Already Know to Take Action
por: Williams, David R., et al.
Publicado: (2019)

Commentary on strategies for switching antipsychotics
por: Davis, John M, et al.
Publicado: (2008)

A Smart Mobile Health Tool Versus a Paper Action Plan to Support Self-Management of Chronic Obstructive Pulmonary Disease Exacerbations: Randomized Controlled Trial
por: Boer, Lonneke, et al.
Publicado: (2019)

Commentary: Taking the next step in cardiopulmonary bypass management
por: Lodge, Andrew J., et al.
Publicado: (2020)

Anticholinergic drugs and risk of dementia: Time for action?
por: Bell, Brian, et al.
Publicado: (2021)

Taking action to advance the study of race and ethnicity: the Women’s Health Initiative (WHI)
por: Garcia, Lorena, et al.
Publicado: (2022)

Use of antipsychotics for the treatment of intensive care unit delirium
por: Page, Valerie J., et al.
Publicado: (2014)

The time is now for action research
por: Singer, Sara J
Publicado: (2013)

Clinical Trial Diversity in Oncology: FDA Takes Action with Post–Marketing Requirements or Commitments
por: Kim, Janice, et al.
Publicado: (2022)

Increasing prevalence of lifestyle diseases: high time for action
por: Pappachan, M.J.
Publicado: (2011)

Âcimowin Waspison: Cultivating curiosity, sharing stories, and taking steps forward in Canada’s ‘Calls to Action’
por: MacNairn, Ian Adam Smith, et al.
Publicado: (2022)

Four actions Australia should take to advance equitable global access to COVID‐19 vaccines
por: Gleeson, Deborah, et al.
Publicado: (2022)

Cardiovascular Risk Assessment and Management in Developing Countries
por: Mendis, Shanthi
Publicado: (2005)

Taking advantage of unexpected WebCONSORT results
por: Cobo, Erik, et al.
Publicado: (2016)

Processing of meats and cardiovascular risk: time to focus on preservatives
por: Micha, Renata, et al.
Publicado: (2013)

Amblyopia: It is time to take action
por: Kohli, Piyush, et al.
Publicado: (2018)

Commentary: Endovascular therapy of a thoracic aorta mycotic aneurysm: The greatest risk is taking no risk!
por: Merkle-Storms, Julia, et al.
Publicado: (2020)

Diabetes Care: “Taking It to the Limit One More Time”
por: Cefalu, William T., et al.
Publicado: (2017)

Climate change and epilepsy: Time to take action
por: Sisodiya, Sanjay M., et al.
Publicado: (2019)

Recent trends in antipsychotic polypharmacy in the treatment of schizophrenia
por: Yasui‐Furukori, Norio, et al.
Publicado: (2020)

Schizophrenia, Depressive Symptoms, and Antipsychotic Drug Treatment
por: Reynolds, Gavin P, et al.
Publicado: (2021)

Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases
por: Mossman, Brooke T, et al.
Publicado: (2007)

Does acupuncture increase the risk of bleeding in patients taking warfarin?
por: Leem, Jungtae
Publicado: (2015)

Taking control with time management
por: Weeks, M J, et al.
Publicado: (2004)

Cell therapy for refractory angina: time for more ACTion
por: Psaltis, Peter J, et al.
Publicado: (2011)

High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?
por: Reynolds, Gavin P
Publicado: (2021)

Time for full inclusion of community actions in the response to AIDS
por: Collins, Chris J, et al.
Publicado: (2016)

Tardive Dyskinesia in Older Persons Taking Antipsychotics
por: Citrome, Leslie, et al.
Publicado: (2021)

Retinopathy of prematurity: it is time to take action
por: Gilbert, Clare, et al.
Publicado: (2017)

Addressing the problem of obesity and associated cardiometabolic risk in black South African women – time for action!
por: Goedecke, Julia H.
Publicado: (2017)

Take care when taking care of fever after aneurysmal subarachnoid hemorrhage
por: Wolf, Stefan
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_89kkohkm1eitkfdvr47p5fffbh